BioCatalyst

GKOS — GLAUKOS Corp catalysts

2 verified catalyst event(s) for GLAUKOS Corp (ticker GKOS). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alon
Phase 4 · Glaucoma, Open-angle, Ocular Hypertension (OHT)
 GKOS GLAUKOS Corp iDose TR (travoprost intracameral implan ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepha
Phase 2 · Demodex Blepharitis
 GKOS GLAUKOS Corp GLK-321 low dose BID, GLK-321 mid dose B ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.